Roth Capital Starts Bluebird Bio (BLUE) at Buy
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 35
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 35
Join SI Premium – FREE
Roth Capital initiated coverage on Bluebird Bio (NASDAQ: BLUE) with a Buy rating and a price target of $50.00.
For an analyst ratings summary and ratings history on Bluebird Bio click here. For more ratings news on Bluebird Bio click here.
Shares of Bluebird Bio closed at $36.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Starts First Tracks Biotherapeutics (TRAX) at Buy
- Goldman Sachs Upgrades TC Energy (TRP:CN) (TRP) to Buy
- Stifel Starts Whitehawk Therapeutics (WHWK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
